Patient Case Report: Gabapentin-Induced Hypoglycemia.
blood glucose
gabapentin
hypoglycemia
patient case report
Journal
Journal of pharmacy practice
ISSN: 1531-1937
Titre abrégé: J Pharm Pract
Pays: United States
ID NLM: 8900945
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
pubmed:
30
9
2020
medline:
3
5
2022
entrez:
29
9
2020
Statut:
ppublish
Résumé
Gabapentin is an analog of gamma-aminobutyric acid (GABA), but its complete mechanism is not well understood. Common adverse effects from gabapentin include somnolence, sedation, and dizziness. Hyperglycemia is listed as a possible adverse drug reaction in the labeling. Case reports describe hypoglycemia in patients with diabetes, peritoneal dialysis, and/or incomplete medication records. The following case report details a hypoglycemia episode as a potential result of a gabapentin use in a patient without diabetes. A 47-year old, 68 kg, white female presented to the emergency department with altered mental status. Her blood glucose level was 33 mg/dL. Gabapentin was started 1 week prior to the hypoglycemia episode. Her past medical history, concomitant medications, and other laboratory findings were not likely causes of her severe hypoglycemia. Gabapentin appears to have effects on several voltage-gated calcium channels. Hypoglycemia may be due to gabapentin binding to the alpha
Identifiants
pubmed: 32990167
doi: 10.1177/0897190020961229
doi:
Substances chimiques
Amines
0
Calcium Channels
0
Cyclohexanecarboxylic Acids
0
gamma-Aminobutyric Acid
56-12-2
Gabapentin
6CW7F3G59X
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM